Discover why IQVIA Holdings leads in life sciences data & tech with AI-driven services, strong growth, and up to 30% stock ...

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV) today announced the launch of the Patient Centered Endpoints (PCE) solution, an innovative science and ...

Unmatched expertise in patient recruitment and retentionOne of the critical challenges in clinical trials is patient ...

New multiyear collaboration between Florence Healthcare and IQVIA to ensure research sites participating in IQVIA studies have access to best-in-class site enablement technology to streamline ...

Nov 1 (Reuters) - IQVIA Holdings (IQV.N), opens new tab cut its full-year profit forecast on Wednesday, citing weakness in demand for its analytics and medical technology solutions along with the ...

RESEARCH TRIANGLE PARK, N.C. – June 12, 2024 – IQVIA (NYSE:IQV) today announced the launch of One Home for Sites™, a new technology platform that acts as a single sign-on and a single dashboard for ...

IQVIA Holdings Inc. IQV yesterday unveiled a clinical trial technology platform, One Home for Sites. The platform streamlines the process of management of trials by acting as a single sign-on and a ...

The new Iqvia (formerly Quintiles). Randy Berger Photography To continue reading this content, please enable JavaScript in your browser settings and refresh this page ...

The latest announcement is out from IQVIA Holdings ( ($IQV) ). On December 9, 2025, IQVIA Holdings Inc. amended its Fifth Amended and Restated ...

Gross Leverage Ratio (Gross Debt/LTM Adjusted EBITDA) 4.9x Net Leverage Ratio (Net Debt/LTM Adjusted EBITDA) 4.5x ...